GNF-5

製品コードS7526 バッチS752602

化学情報

	Synonyms	N/A	Storage (From the date of receipt)	3 years -20°C powder 1 years -80°C in solvent
	化学式	C₂₀H₁₇F₃N₄O₃
	分子量	418.37	CAS No.	778277-15-9
Solubility (25°C)*	体外	DMSO	84 mg/mL (200.77 mM)
		Water	Insoluble
		Ethanol	Insoluble
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	GNF-5 is a selective and allosteric Bcr-Abl inhibitor with IC50 of 220 nM.
in vitro	GNF-5, when used in combination, suppresses the emergence of resistance mutations in vitro, and displays additive inhibitory activity in biochemical and cellular assays against Bcr-Abl T315I mutant. ^[1] This compound shows potent antiproliferative activity with EC50 of 430 nM and 580 nM against wt-Bcr-Abl and E255K mutant Bcr-Abl transformed cells, respectively. ^[2]
in vivo	GNF-5 (100 mg/kg ) displays efficacy on wild-type and T315I Bcr-Abl dependent proliferation in xenograft and bone marrow transplantation models. Moreover, a combination of this compound (75 mg/kg) results in improved overall survival in a T315I Bcr-Abl BMT model. ^[1]

プロトコル(参考用のみ)

キナーゼアッセイ	Kinetic characterization of Abl inhibition
キナーゼアッセイ	The ATP/NADH-coupled assay system in a 96-well format is used to determine the initial velocity of Abl tyrosine kinase catalyzed peptide phosphorylation. The reaction mixture contained 20 mM Tris-HCl, (pH 8.0), 50 mM NaCl, 10 mM MgCl₂, 2 mM PEP [2-(Phosphonooxy)- 2-propenoic acid) and 20 μg Abl peptide substrate (EAIYAAPFAKKK), fixed or varied (to determine inhibitor kinetic parameters) concentration of this compound applied, 1/50 of the final reaction mixture volume of PK/LDH enzyme (pyruvate kinase/lactic dehydrogenase enzymes from rabbit muscle), 160 μM NADH, 0.16 μM Abl, and ATP added last to start the reaction. Absorbance data are collected every 20s at 340 nm using a SpectraMax M5 Microplate Reader.
細胞アッセイ	細胞株	Ba/F3.p210 cells
	濃度	~10 μM
	反応時間	48 hours
	実験の流れ	Ba/F3.p210 cells are obtained by transfecting the IL-3-dependent murine hematopoietic Ba/F3 cell line with a pEYK vector containing p210BCR-ABL and Bcr-Abl mutations. All cell lines are cultured with 5% CO₂ at 37 °C in RPMI 1640 with 10% fetal bovine serum (FBS) and supplemented with 1% l-glutamine. Parental Ba/F3 cells are similarly cultured with 10% WEHI-conditioned medium as a source of IL-3. Transfected cell lines are cultured in media supplemented with 25 μg/mL zeocin. The 48 h cell proliferation studies are obtained using the CellTiter-Glo assay.
動物実験	動物モデル	Ba/F3.p210 xenograft mouse model
	投薬量	~100 mg/kg bid
	投与方法	p.o.

参考

https://pubmed.ncbi.nlm.nih.gov/20072125/
https://pubmed.ncbi.nlm.nih.gov/20828158/

カスタマーフィードバック

: Data from [Data independently produced by , , Leukemia, 2017, 31(5):1096-1107]

: Data from [Data independently produced by , , Oncotarget, 2017, 8(24):38717-38730]

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

The molecular basis of Abelson kinase regulation by its αI-helix [ Elife, 2024, 12RP92324]	PubMed: 38588001
Structural mechanism of a drug-binding process involving a large conformational change of the protein target [ Nat Commun, 2023, 14(1):1885]	PubMed: 37019905
Structural mechanism of a drug-binding process involving a large conformational change of the protein target [ Nat Commun, 2023, 14(1):1885]	PubMed: 37019905
Src stimulates Abl-dependent phosphorylation of the guanine exchange factor Net1A to promote its cytosolic localization and cell motility [ J Biol Chem, 2023, S0021-9258(23)01915-4]	PubMed: 37271338
Abl kinases can function as suppressors of tumor progression and metastasis [ Front Oncol, 2023, 13:1241056]	PubMed: 37746268
Abl kinases can function as suppressors of tumor progression and metastasis [ Front Oncol, 2023, 10.3389/fonc.2023.1241056]	PubMed: 37746268
Establishment and characterization of immortalized sweat gland myoepithelial cells [ Sci Rep, 2022, 12(1):7]	PubMed: 34997030
Imatinib can act as an Allosteric Activator of Abl Kinase [ J Mol Biol, 2021, 434(2):167349]	PubMed: 34774565
ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice [ Gastroenterology, 2020, S0016-5085(20)30334-6]	PubMed: 32171747
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling [ Nat Commun, 2020, 11(1):5463]	PubMed: 33122628

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。